[et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.6.5″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ sticky_enabled=”0″]A new study published in The Journal of the American Medical Association (JAMA) brings new hope and optimism to the Progeria community.

Get the news here:

Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]